Zenflow CEO Damiano Shares Start-up's Origins, Success in Building the Right Series A Syndicate

Medtech Talk

English - February 27, 2018 05:00 - 33 minutes - 15.2 MB - ★★★★★ - 56 ratings
Investing Business Health & Fitness medtech medical device venture capital health care innovation cardiology start-ups orthopedics digital health fda Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: LRVHealth Tapping Providers for New $100 Million Fund

Next Episode: CEO Stevens Says HeartFlow Took No Shortcuts to Commercialization, Raising $240 million Series E

The Stanford Biodesign program created another promising start-up in Zenflow. Co-founder and CEO Nick Damiano explains how the program's fellows identified the opportunity in BPH and found the right tech to excite investors. Zenflow drew some early capital from unusual sources before embarking on an exhausting pursuit of the right Series A syndicate. Damiano shares some advice for other capital-hungry start-ups.

Overview: Great to see a monster Medtech Series A!

Surprises: Zenflow is working out of some offices with great karma.

Regrets: None. I'm feeling good about this one. I could have asked about the broader team.